The Journal of Heart and Lung Transplantation
Volume 23, Issue 6 , Pages 690-695 , June 2004

Demonstrating time sequence and extent of sustained decrease in native heart ejection fraction after heterotopic transplantation

  • Dinesh A. Sivaratnam, MB, BS, FRACP

      Affiliations

    • Department of Nuclear Medicine, The Alfred Hospital, Melbourne, Australia
    • Corresponding Author InformationReprint requests: Dinesh A. Sivaratnam, FRACP, Department of Nuclear Medicine, The Alfred Hospital, Commercial Road, Melbourne, Victoria 3004, Australia. Telephone: 61-3-9276-2432. Fax: 61-3-9276-2599.
    • ,
  • Michael J. Kelly, MB, BS, FRACP

      Affiliations

    • Department of Nuclear Medicine, The Alfred Hospital, Melbourne, Australia
    • ,
  • Don Esmore, MB, BS, FRACS

      Affiliations

    • Department of Cardiothoracic Surgery, The Alfred Hospital, Melbourne, Australia
    • ,
  • Meroula Richardson, MB, BS, FRACP

      Affiliations

    • Department of Cardiology, The Alfred Hospital, Melbourne, Victoria, Australia
    • ,
  • Victor Kalff, MB, BS, FRACP, FACC

      Affiliations

    • Department of Nuclear Medicine, The Alfred Hospital, Melbourne, Australia

Received 11 December 2002 ,Revised 21 June 2003 ,Accepted 21 July 2003.

References 

  1. McMurray JJ, Stewart S. Epidemiology, aetiology, and prognosis of heart failure. Heart. 2000;83:596–602
  2. Deng MC. Cardiac transplantation. Heart. 2002;87:177–184
  3. Swedberg K  Consensus Trial Study Group . Effects of Enalapril on mortality in severe congestive cardiac failure. N Engl J Med. 1987;316:1429–1435
  4. Packer M, Coats AJ, Fowler MB, et al.  Carvedilol Prospective Randomized Cumulative Survival Study Group   Effect of Cavedilol on survival in severe chronic heart failure. N Engl J Med. 2001;344:1651–1658
  5. Sandner SE, Weiselthaler G, Grimm M, et al.  Survival benefit of cardioverter-defibrillator in patients on the waiting list for cardiac transplantation. Circulation. 2001;104(suppl I):H71–H76
  6. Westaby S. Non-transplant surgery for heart failure. Heart. 2000;83:603–610
  7. Hosenpud JD, Bennett LE, Keck BM, et al.  The registry of the International Society for Heart and Lung Transplantation (Eighteenth official report—2000). J Heart Lung Transplant. 2001;20:805–815
  8. Kadner A, Chen RH, Adams DH. Heterotopic heart transplantation (Experimental development and clinical experience). Eur J Cardiothoracic Surg. 2000;17:474–481
  9. Farrar DJ, Holman WR, McBride LR, et al.  Long-term follow-up of Thoratec ventricular assist device bridge-to-recovery patients successfully removed from support after recovery of ventricular function. J Heart Lung Transplant. 2002;21:516–521
  10. Rose EA, Gelijns AC, Moskowitz AJ, et al.  Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med. 2001;345:1435–1443
  11. Bleasdale RA, Banner NR, Anyanwu AC, Mitchell AG, Khaghani A, Yacoub MH. Determinants of outcome after heterotopic heart transplantation. J Heart Lung Transplant. 2002;21:867–873
  12. Tevaearai HT, Walton GB, Eckhart AD, Keys JR, Koch WJ. Heterotopic transplantation as a model to study functional recovery of unloaded failing hearts. J Thorac Cardiovasc Surg. 2002;124:1149–1156
  13. Tagusari O, Kormos RL, Griffith BP, et al.  Native heart complications after heterotopic heart transplantation (Insight into the potential risk of left ventricular assist device). J Heart Lung Transplant. 1999;18:1111–1119
  14. Callahan RJ, Froelich JW, McKulski KA, Leppo J, Strauss HW. A modified method for the in vivo labeling of red blood cells with Tc-99m. J Nucl Med. 1982;23:315–318
  15. Kelly MJ, Cowie AR, Antonino A, Barton H, Kalff V. An assessment of factors influencing the effectiveness of the modified in vivo Technetium-99m-erythrocyte labeling technique in clinical use. J Nucl Med. 1992;33:2222–2225
  16. Allen MD, Corrie A, Stinson EB, et al.  Noninvasive assessment of donor and native heart function after heterotopic transplantation. J Thorac Cardiovasc Surg. 1988;95:75–81
  17. Cowell RP, Morris-Thurgood J, Yacoub M, et al.  Effects of paced counterpulsation on exercise capacity and hemodynamics after heterotopic heart transplantation. Am J Cardiol. 1995;75:415–417
  18. Morris-Thurgood J, Cowell R, Yacoub M, et al.  Hemodynamic and metabolic effects of paced linkage following heterotopic cardiac transplantation. Circulation. 1994;90:2342–2347
  19. Olivari MT, Levine TB, Ring WS, Simon A, Cohn JN. Normalization of sympathetic nervous system function after orthotopic cardiac transplant in man. Circulation. 1987;76:V62–V64
  20. Delgado R, Radovancevic B, Massin EK, Frazier OH, Benedict C. Neurohormonal changes after implantation of a left ventricular assist system. ASAIO J. 1998;44:299–302
  21. Haas GJ, Wooding-Scott M, Binkley PF, Myerowitz PD, Kelley R, Cody RJ. Effects of successful cardiac transplantation on plasma endothelin. Am J Cardiol. 1993;71:237–240
  22. Lerman A, Kubo SH, Tschumperlin LK, Burnett JC. Plasma endothelin concentrations in humans with end-stage heart failure and after heart transplantation. J Am Coll Cardiol. 1992;20:849–853
  23. Maybaum S, Williams M, Mancini D, et al.  Assessment of synchrony relationship between the native left ventricle and the HeartMate left ventricular assist device. J Heart Lung Transplant. 2002;21:509–515

PII: S1053-2498(03)00348-6

doi: 10.1016/j.healun.2003.07.014

The Journal of Heart and Lung Transplantation
Volume 23, Issue 6 , Pages 690-695 , June 2004

Article Tools

* Image Usage & Resolution